Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Cell Death & Disease|July 21, 2017
Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cellsIlaria Genovese, Annarita Fiorillo, Andrea Ilari, et al.
Molecular Aspects of Medicine|July 29, 2023
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcomingRoberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Journal of Hematology & Oncology|June 12, 2012
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusIsabella Faraoni, Serena Laterza, Davide Ardiri, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Small Molecules Targeting the miRNA-Binding Domain of Argonaute 2: From Computer-Aided Molecular Design to RNA ImmunoprecipitationTeresa Bellissimo, Silvia Masciarelli, Elena Poser, et al.
Genes|August 27, 2021
Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell CarcinomaClaudia Tito, Elena De Falco, Paolo Rosa, et al.
RNA Biology|May 14, 2015
Identification of post-transcriptional regulatory networks during myeloblast-to-monocyte differentiation transitionGiulia Fontemaggi, Teresa Bellissimo, Sara Donzelli, et al.
Cell|December 6, 2005
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesisFrancesco Fazi, Alessandro Rosa, Alessandro Fatica, et al.
Frontiers in Cell and Developmental Biology|June 13, 2020
Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer DevelopmentSilvia Di Agostino, Anna Riccioli, Paola De Cesaris, et al.
FEBS Letters|April 1, 2014
Tumor suppressor microRNAs: a novel non-coding alliance against cancerGiovanni Blandino, Francesco Fazi, Sara Donzelli, et al.
ACS Chemical Biology|June 11, 2014
A small-molecule targeting the microRNA binding domain of argonaute 2 improves the retinoic acid differentiation response of the acute promyelocytic leukemia cell line NB4Silvia Masciarelli, Roberto Quaranta, Ilaria Iosue, et al.
Pageof 10